DIRS.INFO The most relevant business & tech news

☆ Here are Thursday's biggest analyst calls: Nvidia, Netflix, Amazon, Microsoft, Tesla, Meta, Campbell Soup and more
▼ + stars: | 2024-11-14 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Here are Thursday's biggest calls on Wall Street: Citi initiates Gilead Sciences as buy The firm said it is bullish on the biotech company's HIV franchise. Piper Sandler upgrades Campbell Soup to overweight from neutral Piper Sandler said it sees an attractive entry point for the stock. UBS initiates Cogent as buy The firm said it sees meaningful revenue acceleration for the internet services company. Jefferies reiterates Tesla as hold The firm raised its price target on the stock to $300 per share from $195. Morgan Stanley reiterates Meta as overweight The firm said Meta is a major artificial intelligence beneficiary. "

Persons: Piper Sandler, Campbell, Oppenheimer, Jefferies, Tesla, Morgan Stanley, Papa, KeyBanc, Papa John's, BXP, Wells, Wells Fargo, BURL, Meta, Needham, Eli Lilly's Organizations: Citi, Gilead Sciences, HIV, SOVO, UBS, Nvidia, Bank of America, Neutral Bank of America, ISI, Papa Johns International, Company, JPMorgan, Medicines, 3Q, Netflix, Barclays, Airlines, FDA, Novo Nordisk, Microsoft Locations: Europe, Asia, Africa, America, Manhattan, Burlington

☆ This Trump trade is an underappreciated opportunity, says Janus Henderson
▼ + stars: | 2024-11-12 | by ( Michelle Fox | ) www.cnbc.com time to read: +2 min

Financial and energy stocks have jumped since last week's election, but there's another area of opportunity that investors could be missing out on, according to Janus Henderson. The market has rallied since President-elect Donald Trump' s victory, although it took a breather on Tuesday. However, financial stocks may have "gotten in a bit ahead of themselves," said Jeremiah Buckley, a portfolio manager at Janus Henderson. In addition, there is great research and development happening in health care right now, especially in health-care services, Buckley added. Among the funds Buckley oversees at Janus Henderson is the U.S. Dividend Income Fund .

Persons: Janus Henderson, Donald Trump, Jeremiah Buckley, Trump, Buckley, Eli Lilly, Amgen Organizations: Trump, P Health Care Services, UnitedHealth, Gilead Sciences

☆ These are the most overbought stocks after Trump's win this week
▼ + stars: | 2024-11-08 | by ( Pia Singh | In | ) www.cnbc.com time to read: +4 min

Several software companies could be due for a pullback after the stock market's roaring rally this week, fueled by president-elect Donald Trump's election victory as well as robust quarterly earnings reports. Shares of video game makers Take-Two Interactive Software and Electronic Arts are two of the stocks that are technically overbought right now, according to the analysis. The most overbought stock this week was human capital management software company Dayforce, with an RSI of 92.4. But higher prices and expectations of normalizing pricing, which helped Coke guide its organic revenue growth this year to the high end of a prior forecast, could lead the stocks higher. Other oversold stocks include power generation company AES , as well as radio frequency equipment maker Qorvo and Regeneron Pharmaceuticals — the latter two of which were also oversold the previous week.

Persons: Donald Trump's, Trump, Morgan Stanley, Mills, Dr Pepper Organizations: Major, Dow Jones, Nasdaq, CNBC Pro, Companies, Electronic Arts, Software, Gilead Sciences, AES, Regeneron Pharmaceuticals Locations: Major U.S, Gilead

☆ Stocks making the biggest moves premarket: Lyft, SolarEdge, Qualcomm, Moderna and more
▼ + stars: | 2024-11-07 | by ( Brian Evans | ) www.cnbc.com time to read: +5 min

Lyft expects bookings in the current quarter of $4.28 billion to $4.35 billion, while analysts polled by FactSet expected $4.23 billion. SolarEdge — The solar panel inverter stock slipped more than 16% after a third-quarter revenue miss. SolarEdge reported revenue of $261 million, while analysts surveyed by LSEG were looking for $269 million. Third-quarter revenue surpassed Wall Street estimates, and the company expects fourth-quarter revenue of $256 million to $262 million, compared with an estimate of $260 million. Moderna — Shares rallied 7% after Moderna's third-quarter earnings and revenue topped expectations.

Persons: FactSet, SolarEdge, —, Zillow, Gilead, LSEG, Armour, Hershey, Samantha Subin, Hakyung Kim, Sarah Min Organizations: Arm, Wall, LSEG, FactSet, —, Qualcomm, Gilead Sciences, Hershey Locations: Gilead

☆ Stocks making the biggest moves midday: Warner Bros. Discovery, AppLovin, Wolfspeed, Lyft and more
▼ + stars: | 2024-11-07 | by ( Pia Singh | In | ) www.cnbc.com time to read: +4 min

The stock had popped 5.9% on Wednesday after the Republican was elected the 47th president of the U.S. Warner Bros. Lyft expects current-quarter bookings to come in between $4.28 billion to $4.35 billion, topping a FactSet consensus of $4.23 billion. Wolfspeed posted revenue of $195 million for the first fiscal quarter, missing the LSEG consensus forecast by $5 million. Arm posted adjusted earnings per share of 30 cents on revenue of $844 million for the second quarter. AppLovin also guided its fourth-quarter EBITDA of $740 million to $760 million, higher than the $667 million StreetAccount forecast.

Persons: LSEG, Donald Trump's, Armour, —, Lyft, Wolfspeed, AppLovin, Zillow, Alex Harring, Sean Conlon, Hakyung Kim, Yun Li, Lisa Kailai Han Organizations: Bros, Dutch Bros, Trump Media & Technology, Republican, U.S, Warner Bros, —, Discovery, FactSet . Arm Holdings, LSEG, Gilead Sciences Locations: Gilead

☆ Election next week holds big implications for stock market, especially the control of Congress
▼ + stars: | 2024-11-01 | by ( Sarah Min | ) www.cnbc.com time to read: +8 min

But the true implications for investors monitoring the election may lie in which party controls Congress, rather than who will sit in the White House. .SPX YTD mountain S & P 500 The importance of whichever party controls Congress was highlighted by Trump's recent trips outside battleground states such as New Mexico , a state that hasn't voted for a GOP presidential nominee in roughly 20 years. On the other hand, Evercore ISI's Emanuel expects a Harris victory, with a Democratic sweep of Congress, could result in the S & P 500 falling to roughly 5,700. The S & P 500 slid 1%, while the Nasdaq dipped 0.5%. Earnings season continues with about 100 S & P 500 companies confirmed to report.

Persons: Donald Trump, Kamala Harris, Trump, Nanette Abuhoff Jacobson, I'm, Abuhoff Jacobson, hasn't, Brian Burrell, Jay Hatfield, Harris, Hatfield, Evercore ISI's Julian Emanuel, Evercore ISI's Emanuel, Jerome Powell's, Ralph Lauren, Warner, Alex Harring Organizations: NBC, Congress, House, Democratic, Republican, Hartford Investments, GOP, Thornburg Investment Management, Infrastructure Capital Advisors, Senate, Wednesday, Regional Banking, Treasury, Federal Reserve, Dow Jones, Nasdaq, National, Marriott International, Diamondback Energy, Wynn Resorts, Palantir Technologies, NXP Semiconductors, PMI, PMI Services, Services PMI, Petroleum, Brands, Technology, Computer, CVS, Howmet Aerospace, Gilead Sciences, Labor, Consumer, Moderna, Molson Coors Beverage, Halliburton, Hershey Co, Warner Bros, Expedia, Akamai Technologies, Paramount Locations: New Mexico, Albuquerque, Santa Fe , New Mexico, Hartford, Albemarle, Qualcomm, Michigan

☆ Calls of the Day: Gilead, Berkshire Hathaway and SLB
▼ + stars: | 2024-10-21 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCalls of the Day: Gilead, Berkshire Hathaway and SLBThe Investment Committee debate the latest Calls Of The Day

Persons: Berkshire Hathaway Locations: Gilead, Berkshire

☆ Here are Monday's biggest analyst calls: Nvidia, Apple, Amazon, Netflix, Campbell Soup, Gilead, American Express & more
▼ + stars: | 2024-10-07 | by ( Michael Bloom | ) www.cnbc.com time to read: +10 min

Wells Fargo upgrades Gilead to overweight from equal weight Wells says the biopharma company has an attractive setup. Wells Fargo upgrades Canadian National to overweight from equal weight Wells says it sees "accelerating growth" for the railway company. Barclays downgrades Netflix to underweight from equal weight Barclay says the "growth algorithm is getting more complex." Wells Fargo downgrades Amazon to equal weight from overweight Wells says the "positive revision story [is] on pause for Amazon. JPMorgan upgrades Ally Financial to overweight from neutral and downgrades American Express to neutral from overweight JPMorgan downgraded American Express and says it sees "asymmetric risk."

Persons: Jefferies, Wells, Morgan Stanley, it's bullish, Barclay, NFLX, Piper Sandler, Piper, Mizuho, JPMorgan downgrades Lamb Weston, JPMorgan, downgrades Sherwin, Williams, KeyBanc, Bernstein, Campbell, underperform Bernstein, Coupang, CPNG, Barclays downgrades, Avery Dennison, Garmin, Hershey Organizations: Apple, Apple Intelligence LT, UW, Vertiv Holdings, Coty, Barclays, Netflix, MKSI, Mizuho, JPMorgan, Deutsche Bank, Alliance, Deutsche, UBS, NXP, Express, American Express, Barclays downgrades DuPont, DuPont, Bank of America downgrades Constellation Brands, Bank of America, Constellation Brands, Bank of America downgrades Comerica, of America, CMA, Air Products, Hershey Locations: OW, Gilead, Canada, underperform

☆ Goldman Sachs bumps its S&P 500 price target for the 3rd time this year as it sees higher corporate profits ahead
▼ + stars: | 2024-10-07 | by ( Matthew Fox | ) www.businessinsider.com time to read: +3 min

Goldman Sachs raised its S&P 500 year-end price target to 6,000, implying a 5% gain. AdvertisementStrategists at Goldman Sachs raised their S&P 500 year-end price target for the third time this year. The price target increase comes after Kostin and his team set an initial year-end S&P 500 price target of 4,700 late last year. AdvertisementKostin also raised the bank's 12-month S&P 500 price target to 6,300 from 6,000. Kostin's price target forecasts assume the S&P 500 continues to trade at a premium valuation of about 22x forward earnings.

Persons: Goldman Sachs, Goldman, —, Goldman's David Kostin, Kostin, Myers Squibb Organizations: Service, Myers, Warner Bros ., Communacopia Locations: Bristol, Gilead

☆ Lost biblical tree resurrected from 1,000 year-old seed
▼ + stars: | 2024-10-03 | by ( Katie Hunt | ) edition.cnn.com time to read: +6 min

CNN —Botanists have grown a long-lost tree species from a 1,000-year-old seed found in a cave in the Judean Desert in the 1980s. But the scientists conducting the new research weren’t able to identify the type of tree from the seed alone. However, the sample didn’t match any of the known Commiphora species in her database. The tree, which the study authors believe may have a biblical connection, is seen at 12 years old. Yet the tree, which is related to the myrrh tree that’s famed for its resin, never gave off any kind of scent.

Persons: Dr, Sarah Sallon, Louis, Sallon, tsori, “ Sheba, ”, Guy Eisner, Elaine Solowey, ” Sallon, Andrea Weeks, Weeks, it’s, “ guggulterols, Louise Colville, Colville wasn’t, “ Organizations: CNN, Natural Medicine Research, Hadassah University Medical, Communications, Center for Sustainable Agriculture, Arava Institute for Environmental Studies, George Mason University, Royal Botanic Locations: Judean, Jerusalem, Gilead, Jordan, Israel, Africa, Madagascar, Fairfax , Virginia, Kew, London

☆ Biotech stocks are an unappreciated way to profit from lower rates, Goldman says
▼ + stars: | 2024-09-18 | by ( Scott Schnipper | ) www.cnbc.com time to read: +3 min

Biotechnology stocks offer an under-the-radar and unappreciated way to profit from the central bank's looming campaign to start cutting the cost of borrowing, according to Goldman Sachs. Investors may have already begun to anticipate the effect of lower rates on some biotech companies. IBB .SPX mountain 2024-06-30 The iShares Biotechnology ETF has risen more than twice as much as the S & P 500 this quarter. The iShares Biotech ETF is up 7.7% this quarter while the Nasdaq Biotech Index has advanced 7.4%, more than double the 3.2% gain in the S & P 500 since June 30. Year-to-date, Regeneron is up 30.6% and Vertex by 18.3%, both outperforming the 18.1% rise in the S & P 500.

Persons: Goldman Sachs, John Flood, Goldman, Flood, Regeneron Organizations: Biotechnology, Federal Reserve, Gilead Sciences, Nasdaq Biotechnology, IQVIA Holdings, Regeneron Pharmaceuticals, Amgen, Vertex Pharmaceuticals, iShares Biotech, Nasdaq Biotech Locations: Gilead

The hotly anticipated results are in from a landmark pair of major clinical trials of a long-acting, injectable HIV-prevention drug that only requires dosing every six months. The pharma giant has already secured approval for the injectable drug in treating highly drug-resistant HIV. Given the clear statistical superiority of lenacapavir over Truvada, the trial’s blinded phase will now be ended several months early. When taken as prescribed, Truvada is over 99% effective at preventing HIV; Descovy is comparably effective. This chorus is sure to get louder now that lenacapavir is officially highly effective at protecting gay and bisexual men and trans people as well.

Persons: lenacapavir, ”, Jared Baeten, “, ” Jen Kates, ” Gilead, Gilead, Truvada, ViiV Healthcare’s, Amy Killelea, Jirair Ratevosian, Hansel Tookes, ” Tookes, Dr, Boghuma, “ lenacapavir, Tim Horn Organizations: Gilead Sciences, pharma, NBC, Food and Drug Administration, Disease Control, PrEP, Yale School of Nursing, University of Miami Miller School of Medicine, NBC News, Southern, Affordable, CDC, Emory University Locations: Gilead, United States, ”, U.S, Australia, United Kingdom, Arlington , Virginia, America, South Africa, Thailand, Truvada, Atlanta, Saharan Africa

Gilead 's twice-yearly shot reduced HIV infections by 96% in a second large study, the company said Thursday. The positive phase three trial data on lenacapavir sets the stage for likely approval by the U.S. Food and Drug Administration for HIV prevention. The company said 99.9% of participants who received lenacapavir did not acquire HIV, with two cases among 2,180 people. Gilead in June also said lenacapavir was 100% effective at preventing HIV in another late-stage trial with cisgender women. The trial results should lead to an FDA approval and launch in the market by 2025, Yee said.

Persons: Gilead, Daniel O'Day, lenacapavir, Michael Yee, Yee Organizations: U.S . Food, Drug Administration, PrEP, Centers for Disease Control, Jefferies, CNBC, YouTube Locations: Gilead

☆ Stocks making the biggest moves midday: Kroger, Petco, Moderna, Roku and more
▼ + stars: | 2024-09-12 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

That builds on Wednesday's post-earnings rally of nearly 33%, which marked the stock's best day on record. Moderna — The stock plummeted nearly 16% after the drugmaker said it will cut $1.1 billion in expenses by 2027. Interpublic Group of Companies — The advertising stock was trading 2% lower following a downgrade from UBS to sell from neutral. U.S. Bancorp — The bank stock slipped nearly 2% despite announcing a dividend hike and a $5 billion share buyback plan. Oracle – Shares of the software company rose nearly 2% after Bernstein named it a top investment idea .

Persons: Kroger –, Kroger, Moderna, Adam Berlin, Bernstein, Yun Li, Michelle Fox, Sean Conlon, Samantha Subin, Lisa Kailai Han, Sarah Min Organizations: Kroger, Moderna, Gilead Sciences, Alaska Air Group, Interpublic, Companies, UBS, Amazon, Pfizer, Bancorp, Diageo, Bank of America, Wolfe Research, Oracle – Locations: Gilead, Alaska, U.S

☆ Twice-a-year injection reduced risk of HIV infection by 96%, drug company says — more than daily PrEP pill
▼ + stars: | 2024-09-12 | by ( Deidre Mcphillips | ) edition.cnn.com time to read: +2 min

CNN —A drug currently used to treat HIV has also been found to dramatically reduce the risk of infection, significantly more than the primary option available for pre-exposure prophylaxis or PrEP. In a Phase 3 clinical trial, 99.9% of participants who took a twice-a-year injection of lenacapavir for HIV prevention did not acquire an infection, according to data from drugmaker Gilead Sciences. There were only two cases among 2,180 patients – effectively reducing the risk of HIV infection by 96% and proving 89% more effective than Truvada, a pill taken once a day. It’s a “significant breakthrough in HIV prevention,” according to a news release from the World Health Organization in July. Gilead said it will use these trial data to start the drug approval process in multiple countries by the end of the year.

Persons: lenacapavir, ”, Onyema Ogbuagu, Dr, Sanjay Gupta, It’s, Gilead Organizations: CNN, Gilead Sciences, Yale, Research, CNN Health, World Health Organization Locations: Gilead, Argentina, Brazil, Mexico, Peru, South Africa, Thailand, United States, Africa

☆ Here are 4 things we're watching closely in the stock market this week
▼ + stars: | 2024-08-04 | by ( Zev Fima | ) www.cnbc.com time to read: +9 min

Stocks had a rough week, topped off with a pummeling Friday after the July jobs data came in weaker than expected. Until then, bad economic news was good news for the stock market, because it meant the Federal Reserve would start cutting interest rates sooner. On Thursday, a drop in U.S. manufacturing activity for July and a jump in initial jobless claims dragged down the market. Next week is light on economic data, so expect earnings reports and CEO commentaries to drive the market action. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

Persons: Stocks, Dow Jones, Jim Cramer, would've, Eli Lilly, Mounjaro, Berkshire Hathaway, Krystal, Tyson, BAX, Owens, Walt, Oscar Health, CRON, Krispy, Papa, Jim Cramer's, Jim Organizations: Nasdaq, Dow, Reserve, Broadcom, Devices, Palo Alto, PMI, Wynn Resorts, Investors, Wynn, Wynn Palace, U.S . Disney, Management, and Drug Administration, Carlyle Group, Krystal Biotech, Tyson Foods, TSN, Alpha Metallurgical Resources, BioCryst Pharmaceuticals, Axsome Therapeutics, Technologies, Clover Health, Realty Income Corp, Avis Budget Group, CSX Corp, CSX, Simon Property Group, Sterling Construction Company, Teradata Corp, Yum China Holdings, ZoomInfo Technologies, Holdings, Caterpillar, Baxter International, Vulcan Materials Company, Allegheny Technologies Incorporated, Constellation Energy Group, Marathon Petroleum Corp, Owens Corning Inc, Duke Energy Corp, GXO Logistics, Brands, Builders, Wynn Resorts Ltd, WYNN, Rivian Automotive, Devon Energy Corp, GigaCloud Technology Inc, Lumen Technologies, VF Corp, Walt Disney Co, Novo Nordisk, CVS Health, Aurora Cannabis Inc, Emerson Electric Co, Sony Group Corporation, SONY, Inc, ODP Corporation, Icahn Enterprises, MannKind Corp, ACM Research, Brink's Company, AppLovin Corporation, Digital Turbine, Sarepta Therapeutics, Occidental Petroleum Corp, Bros, SolarEdge Technologies, Aspen, Coeur D'Alene Mines Corp, Co, Vistra Energy, Cheniere Energy, Cronos, Himax Technologies, Properties Trust, Papa John's, Paramount Global, Trade, Lab, B2Gold Corp, Honest Company, Gilead Sciences, Growth, Nikola Corporation, Embraer, New Fortress Energy, Construction, Jim Cramer's Charitable, CNBC, Disney, Pixar Locations: Palo, Macau, Las Vegas, Boston, Vegas, Wynn Macau, China, Novo, Coeur, Gilead

☆ Wall Street will look for signs of what's next for the market after a rocky start to August
▼ + stars: | 2024-08-02 | by ( Sarah Min | ) www.cnbc.com time to read: +5 min

The S & P 500 ended the week down by 2%. As of Friday, the Nasdaq Composite was more than 10% below its recent high, while the S & P 500 was down by 5.7%. Markets were last pricing in a 71% chance of a half percentage point rate cut in September, up from 22% on Thursday, according to the CME FedWatch Tool . Brands , Fidelity National Information Services , Uber Technologies , Marathon Petroleum , Caterpillar Wednesday Aug. 7 3 p.m. Consumer Credit (June) Earnings: Costco Wholesale , Warner Bros. Discovery , Occidental Petroleum , Ralph Lauren , CVS Health , Hilton Worldwide Holdings , Walt Disney Company Thursday Aug. 8 8:30 a.m.

Persons: Stocks, payrolls, Bill Hornbarger, Benjamin F, Edwards, Russell, Claudia Sahm, selloff, Michael Kantrowitz, Piper Sandler, Kantrowitz, Jan Hatzius, Goldman Sachs, Hatzius, CNBC's, Eli Lilly, Ralph Lauren, Martin Marietta Organizations: Nasdaq, Treasury, Investors, Federal Reserve, Walt Disney Company, Caterpillar, Costco, Micro Computer, PMI, PMI Services, Services PMI, Simon Property Group, Diamondback Energy, Tyson Foods, Devon Energy, Airbnb, Wynn Resorts, TransDigm, Brands, Fidelity National Information Services, Uber Technologies, Marathon Petroleum, Consumer Credit, Costco Wholesale, Warner Bros, Discovery, Occidental Petroleum, CVS Health, Hilton Worldwide Holdings, Gilead Sciences, Akamai Technologies, News Corp, Paramount Global, Expedia, Martin, Martin Marietta Materials Locations: Fortinet, Devon

☆ Forget Big Tech — stocks like these have the biggest upside potential in a volatile market, investor says
▼ + stars: | 2024-07-31 | by ( Weizhen Tan | ) www.cnbc.com time to read: +3 min

"A big tech stock reckoning and correction is inevitable," the chief investment officer told CNBC's " Street Signs Asia " on Tuesday. Calling the euphoria around Big Tech stocks this year "absurd," he said that such excessive investor sentiment and "overdone" momentum "always ends the same." "The biggest risk for the stock market right now is excessive valuations. Such sectors include health care, consumer staples, utilities, and the midstream part of the energy sector, according to him. "The consumers staples sector is being overlooked right now in the market as investors chase returns in the tech sector," he added.

Persons: David Bahnsen, CNBC's, Bahnsen, Mills Organizations: Big Tech, Electric, Gilead Sciences, Mills . American Electric Power, Food Locations: United States, Biopharmaceutical, Gilead

☆ Wall Street says buy stocks that pay dividends with $6 trillion of cash ready to be deployed
▼ + stars: | 2024-07-31 | by ( Matthew Fox | ) www.businessinsider.com time to read: +3 min

Dividend stocks are set to surge as investors deploy $6 trillion from money-market funds, Bank of America says. Investors could be looking to invest their cash as the Fed gets ready to cut interest rates in September. AdvertisementSome of the highest-yielding S&P 500 companies include Walgreens Boot Alliance, Altria, Verizon, Ford, and AT&T. And while the S&P 500 as a whole offers a dividend yield of about 1.25%, there are nearly 300 S&P 500 stocks that offer a higher yield. AdvertisementSome of the high-paying dividend stocks recommended by Belski include Abbvie, Chevron, Duke Energy, Gilead Sciences, and Pfizer.

Persons: —, Savita Subramanian, Subramanian, BMO's Brian Belski, Belski Organizations: Bank of America, Fed, BMO, Gilead Sciences, Service, Treasury, Walgreens Boot Alliance, Altria, Verizon, Ford, Belski, Duke Energy, Pfizer Locations: Chevron, Gilead, Abbvie

☆ Opinion | JD Vance’s ‘Cat Ladies’ Riff Has Serious ‘Handmaid’s Tale’ Vibes
▼ + stars: | 2024-07-25 | by ( Paul Krugman | ) www.nytimes.com time to read: +1 min

You may have heard about JD Vance’s “childless cat ladies” riff. It’s a statement, as my colleague Jessica Grose writes, that shows the desperation of Republicans who are still “clinging to the tag line that the G.O.P. It’s the kind of comment that makes you wonder if Vance thinks that he has been nominated by the Republican Party to serve as the vice president of the Republic of Gilead. Sorry — yes — Vance knows that our nation is still called the United States of America. But there’s a real “Handmaid’s Tale” vibe to a lot of what we’re hearing from the right.

Persons: JD Vance’s, Vance, they’ve, Kamala Harris, It’s, Jessica Grose, — Vance Organizations: Senate, Republican Party Locations: America, Republic of, United States of America

☆ Twice-yearly shot proves successful at preventing HIV infection among women, trial data shows
▼ + stars: | 2024-07-24 | by ( Jacqueline Howard | ) edition.cnn.com time to read: +9 min

CNN —Two shots a year of a drug currently used to treat HIV infections were dramatically effective at preventing infections in a study among young women and adolescent girls in Africa. The twice-yearly injection of the drug lenacapavir can provide total protection against HIV infections, demonstrating 100% efficacy in Phase 3 trial data released by drugmaker Gilead and published Wednesday in the New England Journal of Medicine. The twice-a-year injections of lenacapavir could add another option at preventing HIV infections to the toolbox. The latest Phase 3 findings are part of Gilead’s PURPOSE program, which comprises five HIV prevention trials around the world. “While Gilead awaits additional phase 3 clinical trial data and the potential regulatory filings for HIV prevention administered twice-yearly, it is too early to state the price of lenacapavir for PrEP (prevention).

Persons: drugmaker Gilead, ” Linda, Gail Bekker, Desmond Tutu, “, ”, Dan Barouch, hasn’t, Gilead, Dr, Jason Zucker, Barouch, ” Zucker, Lenacapavir, Gilead spokeperson, lenacapavir, Sanjay Gupta, Daniel O’Day Organizations: CNN, New England, of Medicine, International AIDS, PrEP, University of Cape, International AIDS Society, Center, Virology, Vaccine, Beth Israel Deaconess Medical, United, lenacapavir, Columbia University Irving Medical Center, ”, US Food and Drug Administration, AIDS, CNN Health, People’s Medicines Alliance, Medicines Locations: Africa, Munich, University of Cape Town, South Africa, Uganda, Argentina, Brazil, Mexico, Peru, Thailand, United States, United Kingdom, Germany, Gilead, Europe

☆ Citi says take profits in AI 'highfliers,' gives safe alternatives if tech shares start to fall
▼ + stars: | 2024-07-09 | by ( Samantha Subin | ) www.cnbc.com time to read: +2 min

It's time for investors to consider taking profits in some high-flying artificial intelligence names, according to Citi. The value of AI linchpin Nvidia has more than doubled year to date, while Super Micro Computer has tripled. Given this backdrop, Pettit recommends investors take profits in popular AI names — most notably the enabler stocks like semiconductors — and allocate funds "across the theme's value chain." MCD YTD mountain Shares this year Several popular consumer staples stocks are in the basket, including Kraft Heinz and J.M. Hartford Financial Services Group is the most negatively correlated stock in the basket, with shares up 25% this year.

Persons: propping, Drew Pettit, Pettit, Kraft Heinz, J.M, Chubb Organizations: Citi, Nvidia, Gilead Sciences, Hartford Financial Services, Allstate, Honeywell, Exxon Mobil . Correction Locations: Biopharmaceutical

☆ Stephen King, Sarah Jessica Parker and More Share Their Top Books of the 21st Century
▼ + stars: | 2024-07-08 | by ( The New York Times Books Staff | ) www.nytimes.com time to read: +26 min

To determine the best books of the 21st century , The New York Times Book Review and The Upshot polled hundreds of literary luminaries. Stephen King Stephen King has written more than 60 books, many of which have been adapted for film and television. Min Jin Lee Min Jin Lee has written two novels: FREE FOOD FOR MILLIONAIRES and PACHINKO, which was one of The Times’s 10 Best Books of 2017. Scott Turow Scott Turow is an attorney and writer best known for legal thrillers like PRESUMED INNOCENT and THE BURDEN OF PROOF. DU BOIS, was one of The Times’s 10 Best Books of 2021.

Persons: Stephen King Stephen King, ”, Ian McEwan ●, Christine Falls, Benjamin Black ●, Donna Tartt, Gillian Flynn ●, Cormac McCarthy ●, Margaret Atwood ●, Sarah Waters ●, Philip Roth ●, Viet Thanh Nguyen, “, Stephen King, Min Jin Lee Min Jin Lee, Anthony Doerr ●, Katherine Boo ●, Colm Tóibín ●, Julie Otsuka ● “, Tara Westover ● “, Matthew Desmond ● “, Marilynne Robinson, Edward P, Jones, Barbara Ehrenreich ●, Phil Klay Karl Ove Knausgaard Karl Ove Knausgaard, Roberto Bolaño ● “, Maggie Nelson ● “, Elena Ferrante ● “, Ben Marcus ● “, Emmanuel Carrère ●, Kazuo Ishiguro ●, Claire Keegan ● “, Peter Handke ●, Denis Johnson ●, Svetlana Alexievich, Bonnie Garmus Bonnie Garmus, Barnes, Nehisi Coates, Barbara Kingsolver ●, Tara Westover, Matt Ridley ●, Harry Potter, Prince, Rowling ●, Dave Eggers ●, Henry David Thoreau, Laura Dassow, Ben Rice ●, Colson Whitehead ●, Timothy Egan Nana Kwame Adjei ‑ Brenyah Nana Kwame Adjei ‑, ZZ Packer, Diana Khoi Nguyen, “ Greenwood, Michael Christie, Solmaz Sharif, Min Jin Lee ● “, George Saunders ● “, Jesmyn Ward, Ted Chiang ●, George Saunders ●, Colson Whitehead, Chimamanda Ngozi, Edwidge Danticat, Aracelis Girmay, Natsuo Kirino, Roberto Bolaño ●, Francisco Goldman ●, Paul Beatty Sarah Jessica Parker Sarah Jessica Parker, Tayari Jones, Sting, Paul Murray ●, Megha Majumdar ●, Anthony Marra ●, Jonathan Franzen ●, Donna Tartt ●, Janika Oza, Patrick Radden Keefe, Sonali Deraniyagala James Patterson James Patterson, Bill Clinton, Dolly Parton, J.D . Barker, Stephen King ● “, Markus Zusak ●, Tara Westover ●, Stieg Larsson, Gillian Flynn, Rowling, Anthony Bourdain ●, Keith Richards, James Fox ●, Dennis Lehane ●, Laura Hillenbrand Elin Hilderbrand Elin Hilderbrand, “ Alice, Oliver, Charles Bock ●, Curtis Sittenfeld, Tim Winton ●, Lily King ● “, Anna Quindlen ●, Lauren Groff ● “, Maggie O'Farrell, Raven Leilani, Erin Morgenstern Annette Gordon ‑ Reed Annette Gordon, Reed, Siddhartha Mukherjee, Annette Gordon, Reed ●, Henrietta, Rebecca Skloot ●, Louis Menand ●, Isabel Wilkerson ●, Hilary, Rebecca Roanhorse Rebecca Roanhorse, Hugo, Ann Leckie ● “, Ted Chiang ● “, Kim Stanley Robinson ●, Stephen Graham Jones ●, Ken Liu ●, Djèlí Clark ●, Louise Erdrich ●, Theodore Sturgeon Marlon James Marlon James, Booker, Maria McCann ● “, Bird, James McBride ●, Alan Hollinghurst ●, Min Jin Lee ●, Skippy, Patrick French Roxane Gay Roxane Gay, Michael Chabon ●, Alicia Erian ●, Bernardine Evaristo, Kiese Laymon, Carmen Maria Machado ●, Zadie Smith, Emma Donoghue ●, Ann Patchett Jonathan Lethem Jonathan Lethem, Eugene Lim ●, Olga Ravn ●, Percival Everett ●, Keith Ridgway ●, Renee Gladman ●, Lydia Millet ● “, Helen DeWitt ● “, Robin McLean ●, Christopher Sorrentino Sarah MacLean Sarah MacLean, Angelina M, Lopez ● “, Lisa Kleypas ●, Jennifer Crusie ●, Circe, Madeline Miller, Kresley Cole ●, Beverly Jenkins ● “ Georgie, Kate Clayborn ● “ Hana Khan, Uzma Jalaluddin, Milla Vane ● “, Sherry Thomas Ed Yong Ed Yong, Bel Canto, Ann Patchett, Nana Kwame Adjei, Abed Salama, Nathan Thrall, Mohsin Hamid ● “, Helen Macdonald ● “, Jenny Odell ●, Julie Otsuka, Amal El, Max Gladstone ●, Hernan Diaz, Thomas Chatterton Williams Thomas Chatterton Williams, Hagar's, Jones ●, Catherine Lacey ● “, Dana Spiotta, Joan Silber ● “ Malcolm X, Manning Marable, Alice Munro ●, Hua Hsu, Veronica, Mary Gaitskill ●, Isabel Wilkerson Paul Tremblay Paul Tremblay, Mark Z, Joker, Kaoru Takamura ●, Benjamín Labatut, Stephen Graham Jones, Mariana Enriquez ●, Sara Levine ●, Colson Whitehead Nick Hornby Nick Hornby, Michael Chabon, David Kynaston ●, Billy Lynn's, Ben Fountain ●, Richard Russo, Olive Kitteridge, Elizabeth Strout ●, Mark Harris ●, Adrian Nicole LeBlanc ●, Scott Turow Scott Turow, Sam Quinones ● “, Elena Ferrante, Ann Goldstein, ●, Timothy Snyder ●, Adam Johnson ●, Ann Goldstein ●, Daniel Kahneman ● “, Daniel Alarcón Daniel Alarcón, Oscar Wao, Junot Díaz, Claudia Rankine, Jones ● “, Adrian Nicole LeBlanc ● “, Patrick Radden Keefe Honorée Fanonne Jeffers Honorée Fanonne Jeffers, Victor Luckerson ●, Alice Walker ●, Toni Morrison ●, Toni Morrison ● “, Ibram X, Tiya Miles ●, Isabel Wilkerson Lucy Sante Lucy Sante, Uwe Johnson, Damion Searls, Jeremiah Moss ●, Sigrid Nunez ●, Ian Penman, Mike DeCapite ●, Rachel Kushner ●, Ed Park ●, Svetlana Alexievich Gary Shteyngart Gary Shteyngart, Pitchaya Sudbanthad, Amy Hempel, Amy Hempel ● “, Colm Tóibín, Joseph O’Neill ●, Rachel Cusk ●, Tony Judt ●, Isabel Wilkerson Anand Giridharadas Anand Giridharadas, Jane Mayer ●, Andrew Solomon ● “, Hanya Yanagihara, Suketu Mehta, Karl Ove Knausgaard ●, Asne Seierstad, Joan Didion Jessamine Chan Jessamine, Barack Obama, Tang, Chloé Cooper Jones, Andrea Elliott ● “, Jenny Erpenbeck, Lauren Groff ●, Cathy Park Hong, Sheila Heti ●, Dorothy Roberts Michael Robbins Michael Robbins, Michael Robbins, Kristin Ross ●, Lauren Berlant, Andreas Malm ●, Anahid Nersessian, “ Lila, Mike Davis ●, Chelsey Minnis, Fred Moten ●, Mary Gaitskill Alma, Alma Katsu, Jonathan Strange, Norrell, Susanna Clarke ● “, Sarah Waters, Julie Otsuka ●, Audrey Niffenegger ●, Megan Abbott Megan Abbott, Edgar, Joyce Carol Oates, Kate Atkinson ●, Robert Kolker ●, Oyinkan Braithwaite ●, Daniel Woodrell ●, Joan Didion Joshua Ferris Joshua Ferris, Hemingway, Anne Enright, Patricia Lockwood ●, Paul Harding ●, Ann Napolitano Ann Napolitano, David Mitchell ●, Yaa Gyasi, Emily St, John Mandel ●, John Irving John Irving, OWEN MEANY, John Boyne, Paul Theroux, Abraham Verghese ●, James Salter ●, Nix, Nathan Hill, Edmund White ●, Peter Matthiessen ●, Michael Ondaatje ●, Jeanette Winterson Tiya Miles Tiya Miles, Frederick Douglass, David W, Blight, Andrew Sean Greer ●, Michael Pollan ●, Dara Horn ●, Stephen Greenblatt ●, Jami Attenberg Jami Attenberg, Ada Limón ●, Jonathan Franzen, Alison Bechdel, Sloane Crosley, Alexander Chee ●, Patti Smith ●, Morgan Parker ●, Sara Novic Stephen L, Carter Stephen L, Carter, Deirdre McCloskey ●, Mohsin Hamid ●, Virginia Postrel, Umberto, Geraldine Brooks ●, Richard Powers ●, Jane Brox ●, David Bentley Hart, Lesley Nneka Arimah, Sarah Schulman Sarah Schulman, Mattilda Bernstein, Natasha Trethewey ●, Adania Shibli, Ned Blackhawk ●, Stephanie E, Rogers, Martha S, Steven W, Raja Shehadeh ●, Hugh Ryan Elizabeth Hand Elizabeth Hand, Rene Denfeld ●, Henry Darger, John M, MacGregor ● “, Dan Chaon ● “ James Tiptree Jr, Julie Phillips ●, Kelly Link, Morgan Talty ●, Robert Macfarlane ●, William Gibson Dion Graham Dion Graham, Jonathan Eig’s, Colson Whitehead’s CROOK, Omar El Akkad, Wolf, Marlon James ● “, Winfred Rembert, Cixin Liu ● “, Dave Eggers ● “, George Floyd, Robert Samuels, Toluse, Jonathan Eig ●, Jonathan Eig ● “ Washington, Jeremy Denk Jeremy Denk, David Foster Wallace ●, Jeff, Geoff Dyer ●, Hanif Abdurraqib, Elif Batuman, Alex Ross ●, Kate Molleson Morgan Jerkins Morgan Jerkins, Zora Neale Hurston, Haruki Murakami ●, Masha Gessen ●, Safiya Sinclair ● “, Carmen Maria Machado ● “, Imani Perry, Jesmyn Ward Michael Roth Michael Roth, Amy Bloom, Saidiya Hartman, Valeria Luiselli ●, Jon Fosse, Daniel Kahneman ●, Ben Lerner ●, Jennifer Egan Organizations: New York, Argonauts, J.K, Railroad, Corrections, ”, A.M, Harvard University, OF, Metaphysical, Suns, Ministry, Indians, The New York Times, Hawthorn, Child, Roberto Bolaño ● “, New Yorker, NPR, University of Oklahoma, DU BOIS, PEN, “, Yale Law School, THE, Umberto Eco, Beginners, MacArthur Foundation, Wesleyan University, Topeka School Locations: ”, Brooklyn, Norwegian, Ben Marcus ● “ The, Nantucket, OF MONTICELLO, Monticello, “, BROOKLYN, Britain, Jones ● “ Lincoln, Feral, Bangkok, Susanna Clarke ● “ Lincoln, Burma, Texas, Jonathan Eig ● “, “ Austerlitz, Venice, Death, Varanasi, America, Lorraine

☆ Stocks making the biggest moves premarket: Paramount, SolarEdge, Morphic Holding and more
▼ + stars: | 2024-07-08 | by ( Hakyung Kim | ) www.cnbc.com time to read: +2 min

Morphic Holding — Shares surged more than 75% on news that Eli Lilly will acquire the biopharma company in a $3.2 billion deal . The deal will give Eli Lilly access to Morphic's portfolio of treatments in development, such as those for ulcerative colitis and Crohn's disease. Eli Lilly shares inched up 0.2% on the news. SolarEdge — The energy company rose 5% after Bank of America upgraded shares to neutral from underperform, citing an attractive entry point for investors. Gilead — Shares of the biotech stock rose more than 2% after an upgrade to outperform from market perform at Raymond James.

Persons: Eli Lilly, SolarEdge, Guggenheim, ServiceNow, John DiFucci, Baird, Gilead —, Raymond James, Gilead, Sarah Min, Jesse Pound, Michelle Fox, Yun Li Organizations: Paramount, Skydance Media, Bank of America, PNC, UBS, KeyCorp, Columbia, —

☆ Stocks making the biggest moves midday: Paramount Global, Morphic Holding, Ideaya Biosciences and more
▼ + stars: | 2024-07-08 | by ( Sean Conlon | ) www.cnbc.com time to read: +3 min

Skydance and its financial backers will invest more than $8 billion into Paramount and to acquire National Amusements, Paramount's controlling shareholder. Morphic Holding – Shares rallied 75% on news that Eli Lilly will acquire the biopharmaceutical company in a $3.2 billion deal . The deal will give Eli Lilly access to Morphic's portfolio of treatments in development, such as those for ulcerative colitis and Crohn's disease. Shares of Eli Lilly advanced 1.3% on the news. Boeing – Shares fell slightly after the airplane maker agreed to plead guilty to criminal fraud related to the fatal 737 Max crashes, sparing Boeing from a trial.

Persons: Eli Lilly, BofA, Corning, Guggenheim, Max, Grayson, Raymond James, Samantha Subin, Pia Singh, Hakyung Kim, Sarah Min, Michelle Fox Organizations: Paramount Global, Skydance Media, Skydance, Paramount, National, Morphic, Ideaya Biosciences, Bank of America, Boeing –, Boeing, ., CNBC, Devon Energy, Gilead Sciences Locations: Columbia, Stifel, Williston, Gilead

Search resuls for: "gilead"

25 mentions found